K., Sakurai, T., Yanagisawa, M. & Nakazato, M. (1999) Orexins, orexigenic
hypothalamic peptides, interact with autonomic, neuroendocrine and
neuroregulatory systems. Proc. Natl. Acad. Sci. USA, 96, 748–753.
Dijk, D.J. & Czeisler, C.A. (1994) Paradoxical timing of the circadian rhythm
of sleep propensity serves to consolidate sleep and wakefulness in humans.
Neurosci. Lett., 166, 63–68.
Edgar, . D.M., Dement, W.C. & Fuller, C.A. (1993) Effect of SCN-lesions on
sleep in squirrel monkeys: evidence for opponent processes in sleep-wake
regulation. J. Neurosci., 13, 1065–1079.
Franken, P., Tobler, I. & Borbely, A.A. (1991) Sleep homeostasis in the rat:
simulation of the time course of EEG slow-wave activity. Neurosci. Lett.,
130, 141–144.
Fujiki, N., Yoshida, Y., Ripley, B., Honda, K., Mignot, E. & Nishino, S.
(2001) Changes in CSF hypocretin-1 (orexin A) levels in rats across 24
hours and in response to food deprivation. Neuroreport, 12, 993–997.
Hagan, J.J., Leslie, R.A., Patel, S., Evans, M.L., Wattam, T.A., Holmes, S.,
Benham, C.D., Taylor, S.G., Routledge, C., Hemmati, P., Munton. R.P.,
Ashmeade, T.E., Shah, A.S., Hatcher, J.P., Hatcher, P.D., Jones, D.N.,
Smith, M.I., Piper, D.C., Hunter, A.J., Porter, R.A. & Upton, N. (1999)
Orexin A activates locus coeruleus cell firing and increases arousal in the
rat. Proc. Natl. Acad. Sci. USA, 96, 10911–10916.
Hara, J., Beuckmann, C.T., Nambu, T., Willie, J.T., Chemelli, R.M., Sinton,
C.M., Sugiyama, F., Yagami, K., Goto, K., Yanagisawa, M. & Sakurai, T.
(2001) Genetic ablation of orexin neurons in mice results in narcolepsy,
hypophagia, and obesity. Neuron, 30, 345–354.
Hishikawa, Y., Wakamatsu, H., Furuya, E., Sugita, Y., Masaoka, S., Kaneda,
H., Sato, M., Nan'no, H. & Kaneko, Z. (1976) Sleep satiation in narcoleptic
patients. Electroencephalogr. Clin. Neurophysiol., 41, 1–18.
Jones, B.E. (1994) Basic mechanism of sleep-wake states. In Kryger, M.H.,
Roth, T. & Dement, W.C., (eds), Principles and Practice of Sleep Medicine.
W.B. Saunders Co., Philadelphia, pp. 145–162.
Kilduff, T.S. & Peyron, C. (2000) The hypocretin/orexin ligand-receptor
system: implications for sleep and sleep disorders. Trends Neurosci, 23,
359–365.
de Lecea, L., Kilduff, T., Peyron, C., Gao, X.-B., Foye, P.E., Danielson, P.E.,
Fukuhara, C., Battenberg, E.L.F., Gautvik, V.T., Bartlett, F.S., Frankel,
W.N., van den Pol, A.N., Bloom, F.E., Gautvik, K.M. & Sutcliffe, J.G.
(1998) The hypocretins: hypothalamus-specific peptides with
neuroexcitatory activity. Proc. Natl. Acad. Sci. USA, 95, 322–327.
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong,
P.J., Nishino, S. & Mignot, E. (1999) The sleep disorder canine narcolepsy
is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 98,
365–376.
Marcus, J.N., Aschkenasi, C.J., Lee, C.E., Chemelli, R.M., Saper, C.B.,
Yanagisawa, M. & Elmquist, J.K. (2001) Differential expression of orexin
receptors 1 and 2 in the rat brain. J. Comp. Neurol., 435, 6–25.
Matsumura, H., Kinoshita, G., Satoh, S., Osaka, T. & Hayaishi, O. (1995) A
novel apparatus that permits multiple routes for infusions and body-fluid
collections in a freely-moving animal. J. Neurosci. Meth., 57, 145–149.
Matsumura, H., Nakajima, T., Osaka, T., Satoh, S., Kawase. K., Kubo, E.,
Kantha, S.S., Kasahara, K. & Hayaishi, O. (1994) Prostaglandin D2- sensitive, sleep-promoting zone defined in the ventral surface of the rostral
basal forebrain. Proc. Natl. Acad. Sci. USA, 91, 11998–12002.
Mitler, M.M., Gujavarty, K.S. & Browman, C.P. (1982) Maintenance of
wakefulness test: a polysomnographic technique for evaluation treatment
efficacy in patients with excessive. somnolence. Electroencephalogr. Clin.
Neurophysiol., 53, 658–661.
Montplaisir, J. (1976) Distrubed nocturnal sleep. In Guilleminault, C.,
Dement, W.C. & Passouant, P., (eds), Narcolepsy, Spectrum, New York,
pp. 43–56.
Nakamura, T., Uramura, K., Nambu, T., Yada, T., Goto, K., Yanagisawa, M.
